Published in Clin Rheumatol on March 06, 2007
Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol (2008) 1.08
Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study. Clin Exp Rheumatol (2010) 0.97
Psychologic interventions and lifestyle modifications for arthritis pain management. Rheum Dis Clin North Am (2008) 0.93
Association of morbid obesity with disability in early inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken) (2013) 0.91
Future perspectives of Smartphone applications for rheumatic diseases self-management. Rheumatol Int (2014) 0.84
Prevalence of overweight in Moroccan patients with rheumatoid arthritis and its relationships with disease features. Clin Rheumatol (2011) 0.82
Impact of Bariatric Surgery on Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken) (2015) 0.81
Association of body mass index with physical function and health-related quality of life in adults with arthritis. Arthritis (2013) 0.79
The steps to health randomized trial for arthritis: a self-directed exercise versus nutrition control program. Am J Prev Med (2014) 0.78
Lack association of body mass index with disease activity composites of rheumatoid arthritis in Korean population: cross-sectional observation. Clin Rheumatol (2013) 0.78
Rheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbidities. Ther Clin Risk Manag (2014) 0.75
Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patients. BMC Musculoskelet Disord (2017) 0.75
Evaluation of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Discriminating between Active and Non-Active Systemic Lupus Erythematosus. Malays J Med Sci (2016) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Actual causes of death in the United States, 2000. JAMA (2004) 44.38
Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 33.23
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum (1995) 26.94
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
SF-36 health survey update. Spine (Phila Pa 1976) (2000) 12.41
Elevated C-reactive protein levels in overweight and obese adults. JAMA (1999) 9.94
Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11
The mortality of rheumatoid arthritis. Arthritis Rheum (1994) 6.18
The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med (2004) 5.77
Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ (2002) 4.92
Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA (2003) 4.76
Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol (1995) 3.76
The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am (2001) 3.58
Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum (1984) 3.33
The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health (Oxf) (2005) 2.85
Obesity and physical and emotional well-being: associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire. Obes Res (2000) 2.21
Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens (2003) 2.12
Obesity and health-related quality of life: a cross-sectional analysis of the US population. Int J Obes Relat Metab Disord (2003) 1.85
Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants. Br J Rheumatol (1998) 1.81
Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med (2005) 1.77
Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum (2004) 1.67
Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania. Ann Rheum Dis (2003) 1.58
Obesity in the United States: a fresh look at its high toll. JAMA (2003) 1.53
Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis. J Rheumatol (2006) 1.53
Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes (2006) 1.49
Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases. J Rheumatol (2005) 1.40
Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis. Br J Rheumatol (1997) 1.33
Impact of weight loss and regain on quality of life: mirror image or differential effect? Obes Res (2003) 1.22
Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enteral Nutr (2004) 1.18
How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol (2005) 1.15
A comparison between BMI and Conicity index on predicting coronary heart disease: the Framingham Heart Study. Ann Epidemiol (2000) 1.13
The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. Br J Gen Pract (2004) 0.96
How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study. Clin Rheumatol (2000) 0.94
The health-related quality of life of patients with epilepsy compared with angina pectoris, rheumatoid arthritis, asthma and chronic obstructive pulmonary disease. Qual Life Res (2000) 0.91
Estimating utility values for health states of overweight and obese individuals using the SF-36. Qual Life Res (2005) 0.91
Health-related quality of life in rheumatoid arthritis in Northern Sweden: a comparison between patients with early RA, patients with medium-term disease and controls, using SF-36. Clin Rheumatol (2004) 0.89
[Quality of life in relation to health and obesity in a primary care center]. Rev Esp Salud Publica (1998) 0.84
Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med (2009) 7.89
Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol (2006) 3.10
Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med (2010) 2.90
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes (2009) 1.90
Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Gastroenterology (2007) 1.80
Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum (2005) 1.80
Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis. Med Care (2007) 1.62
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum (2009) 1.56
Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum (2009) 1.45
Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. J Rheumatol (2008) 1.24
Computerized definitions showed high positive predictive values for identifying hospitalizations for congestive heart failure and selected infections in Medicaid enrollees with rheumatoid arthritis. Pharmacoepidemiol Drug Saf (2008) 1.23
An automated database case definition for serious bleeding related to oral anticoagulant use. Pharmacoepidemiol Drug Saf (2011) 1.14
Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum (2008) 1.06
Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2010) 1.02
Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis (2007) 1.00
Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors. Arch Drug Inf (2009) 0.99
Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum (2010) 0.96
Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J Rheumatol (2007) 0.94
Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. Lupus (2008) 0.93
Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus. Lupus (2007) 0.89
Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther (2013) 0.87
Endothelial function in systemic lupus erythematosus: relationship to disease activity, cardiovascular risk factors, corticosteroid therapy, and coronary calcification. Vasc Health Risk Manag (2005) 0.85
Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis. Atherosclerosis (2011) 0.83
Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort. Rheumatology (Oxford) (2012) 0.83
Pan-American League of Associations for Rheumatology (PANLAR) recommendations and guidelines for musculoskeletal ultrasound training in the Americas for rheumatologists. J Clin Rheumatol (2010) 0.83
The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores. Arthritis Rheumatol (2015) 0.82
Pleiotrophin differentially regulates the rewarding and sedative effects of ethanol. J Neurochem (2014) 0.80
Gonococcal arthritis of the shoulder and septic extensor tenosynovitis of the wrist: sonographic appearances. J Ultrasound Med (2003) 0.80
Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors. Arch Drug Inf (2008) 0.78
Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome. Arthritis Care Res (Hoboken) (2014) 0.77
Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis. Clin Rheumatol (2015) 0.76
The effect of low-dose prednisone on bone mineral density in Peruvian rheumatoid arthritis patients. Rheumatol Int (2003) 0.75